Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems

被引:308
作者
Scholzen, T
Armstrong, CA
Bunnett, NW
Luger, TA
Olerud, JE
Ansel, JC
机构
[1] Emory Univ, Sch Med, Dept Dermatol, Atlanta, GA 30322 USA
[2] Vet Affairs Med Ctr, Dermatol Serv, Atlanta, GA 30033 USA
[3] Univ Washington, Dept Dermatol, Seattle, WA 98195 USA
[4] Univ Calif San Francisco, Dept Physiol & Surg, San Francisco, CA 94143 USA
[5] Univ Munster, Ludwig Boltzmann Inst Cellbiol & Immunobiol Skin, Dept Dermatol, D-4400 Munster, Germany
关键词
neuropeptides; skin immune system; substance; calcitonin-gene-related peptide; sensory nerves;
D O I
10.1111/j.1600-0625.1998.tb00307.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The interaction between components of the nervous system and multiple target cells in the cutaneous immune system has been receiving increasing attention. It has been observed that certain skin diseases such as psoriasis and atopic dermatitis have a neurogenic component. Neuropeptides released by sensory nerves that innervate the skin and often contact epidermal and dermal cells can directly modulate functions of keratinocytes, Langerhans cells (LC), mast cells, dermal microvascular endothelial cells and infiltrating immune cells, Among these neuropeptides the tachykinins substance P (SP) and neurokinin A (NKA), calcitonin gene-related peptide (CGRP), vasoactive intestinal peptide (VIP) and somatostatin (SOM) have been reported to effectively modulate skin and immune cell functions such as cell proliferation, cytokine production or antigen presentation under physiological or pathophysiological conditions. Expression and regulation of their corresponding receptors that are expressed on a variety of skin cells as well as the presence of neuropeptide-specific peptidases such as neutral endopeptidase (NEP) or angiotensin-converting enzyme (ACE) determine the final biological response mediated by these peptides on the target cell or tissue. Likewise, skin cells like keratinocytes or fibroblasts are a source for neurotrophins such as nerve growth factor that are required not only for survival and regeneration of sensory neurons but also to control responsiveness of these neurons to external stimuli. Therefore, neuropeptides, neuropeptide receptors, neuropeptide-degrading enzymes and neurotrophins participate in a complex, interdependent network of mediators that modulate skin inflammation, wound healing and the skin immune system. This review will focus on recent studies demonstrating the role of tachykinins, CGRP. SOM and VIP and their receptors and neuropeptide-degrading enzymes in mediating neurogenic inflammation in the skin.
引用
收藏
页码:81 / 96
页数:16
相关论文
共 199 条
[41]  
Christian Christine, 1994, Neuroimmunomodulation, V1, P159, DOI 10.1159/000097156
[42]  
CHURCH MK, 1991, SKIN PHARMACOL, V4, P15
[43]   EFFECTS OF CGRP IN DIFFERENT MODELS OF MOUSE EAR INFLAMMATION [J].
CLEMENTI, G ;
AMICOROXAS, M ;
CARUSO, A ;
CUTULI, VMC ;
PRATO, A ;
MAUGERI, S ;
DEBERNARDIS, E ;
SCAPAGNINI, U .
LIFE SCIENCES, 1994, 54 (08) :PL119-PL124
[44]   Substance P activates the release of histamine from human skin mast cells through a pertussis toxin-sensitive and protein kinase C-dependent mechanism [J].
Columbo, M ;
Horowitz, EM ;
KageySobotka, A ;
Lichtenstein, LM .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1996, 81 (01) :68-73
[45]  
Cone RD, 1996, RECENT PROG HORM RES, V51, P287
[46]  
DOCKRAY GJ, 1979, FED PROC, V38, P2295
[47]  
DRAY A, 1996, NEUROGENIC INFLAMMAT, P69
[48]   Aspartate 196 in the first extracellular loop of the human VIP1 receptor is essential for VIP binding and VIP-stimulated cAMP production [J].
Du, K ;
Nicole, P ;
Couvineau, A ;
Laburthe, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 230 (02) :289-292
[49]   INNERVATION OF THE CEREBRAL VASCULATURE [J].
DUCKLES, SP .
ANNALS OF BIOMEDICAL ENGINEERING, 1983, 11 (06) :599-605
[50]   A potent and selective CGRP(2) agonist, [Cys(Et)(2,7)]hCGRP alpha: comparison in prototypical CGRP(1) and CGRP(2) in vitro bioassays [J].
Dumont, Y ;
Fournier, A ;
StPierre, S ;
Quirion, R .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1997, 75 (06) :671-676